These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20621586)

  • 1. Oral ileocolonic drug delivery by the colopulse-system: a bioavailability study in healthy volunteers.
    Schellekens RC; Stellaard F; Olsder GG; Woerdenbag HJ; Frijlink HW; Kosterink JG
    J Control Release; 2010 Sep; 146(3):334-40. PubMed ID: 20621586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
    Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
    J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets.
    Maurer JM; Schellekens RC; van Rieke HM; Wanke C; Iordanov V; Stellaard F; Wutzke KD; Dijkstra G; van der Zee M; Woerdenbag HJ; Frijlink HW; Kosterink JG
    PLoS One; 2015; 10(7):e0129076. PubMed ID: 26177019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotope-labelled urea to test colon drug delivery devices in vivo: principles, calculations and interpretations.
    Maurer MJ; Schellekens RC; Wutzke KD; Stellaard F
    Isotopes Environ Health Stud; 2013; 49(4):473-91. PubMed ID: 24313370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-invasive, low-cost study design to determine the release profile of colon drug delivery systems: a feasibility study.
    Maurer MJ; Schellekens RC; Wutzke KD; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG; Stellaard F
    Pharm Res; 2012 Aug; 29(8):2070-8. PubMed ID: 22422322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers.
    Johnson FK; Stark JG; Bieberdorf FA; Stauffer J
    Clin Ther; 2010 Jun; 32(6):1149-64. PubMed ID: 20637968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoscintigraphic assessment of the regional drug absorption of the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240, in healthy volunteers.
    Martin NE; Collison KR; Martin LL; Tardif S; Wilding I; Wray H; Barrett JS
    J Clin Pharmacol; 2003 May; 43(5):529-38. PubMed ID: 12751274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile drug-delivery systems.
    Bussemer T; Otto I; Bodmeier R
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):433-58. PubMed ID: 11763497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system.
    Bott C; Rudolph MW; Schneider AR; Schirrmacher S; Skalsky B; Petereit HU; Langguth P; Dressman JB; Stein J
    Aliment Pharmacol Ther; 2004 Aug; 20(3):347-53. PubMed ID: 15274672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products.
    Strusi OL; Barata P; Traini D; Young PM; Mercuri S; Colombo G; Sonvico F; Bettini R; Colombo P
    J Control Release; 2010 Aug; 146(1):54-60. PubMed ID: 20457192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice.
    Gareb B; Dijkstra G; Kosterink JGW; Frijlink HW
    Int J Pharm; 2019 Jan; 554():366-375. PubMed ID: 30414898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic technology).
    Sangalli ME; Maroni A; Busetti C; Zema L; Giordano F; Gazzaniga A
    Boll Chim Farm; 1999 Mar; 138(3):68-73. PubMed ID: 10394705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proof-of-concept study on the suitability of 13C-urea as a marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms.
    Schellekens RC; Olsder GG; Langenberg SM; Boer T; Woerdenbag HJ; Frijlink HW; Kosterink JG; Stellaard F
    Br J Pharmacol; 2009 Sep; 158(2):532-40. PubMed ID: 19732063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption of rivastigmine from different regions of the gastrointestinal tract in humans.
    Lee L; Hossain M; Wang Y; Sedek G
    J Clin Pharmacol; 2004 Jun; 44(6):599-604. PubMed ID: 15145967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
    Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
    J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: A clinical pharmacoscintigraphy study.
    Preisig D; Varum F; Bravo R; Hartig C; Spleiss J; Abbes S; Caobelli F; Wild D; Puchkov M; Huwyler J; Haschke M
    Eur J Pharm Biopharm; 2021 Aug; 165():22-30. PubMed ID: 33971274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.